Mergers & Acquisitions ·
On August 20, 2026, Meiwu Technology Company Limited's wholly owned subsidiary, Xiamen Chunshang Health Technology…
WNWMeiwu Technology Co Ltd
On August 20, 2026, Meiwu Technology Company Limited's wholly owned subsidiary, Xiamen Chunshang Health Technology Co., Ltd., entered into an equity transfer agreement to acquire 100% of Xiamen Hemeitong Commercial Co., Ltd. for RMB 23,520,000 (approximately $35,000,000) in cash. The purchase price aligns with a valuation report from Beijing Yingyue Asset Appraisal Co., Ltd., which valued the target at RMB 239,405,140 as of June 30, 2026. Xiamen Hemeitong serves as a distributor for functional skincare products in Southern and Eastern China, maintaining access to approximately 1,600 brand owners, retailors, and beauty salons. Meiwu Technology aims to leverage this network to accelerate the adoption of its AI-assisted platform, MOBO App, thereby enhancing data collection and operational capabilities within the Chinese health and skincare sector.